Chromosomal abnormalities of patients with AML or MDS.

Patients were identified as having chromosome 5, 7, 17, or 16 abnormalities by reviewing the karyotypes. Each patient has 1 or more cytogenetic changes and karyotypic abnormalities are not exclusive to these 4 chromosomes. The last bar includes only those patients with a 5q abnormality and inv(16) and no other 16 abnormality.